Hemab Therapeutics Holdings, Inc.: which funds bought and sold
Institutions that bought and sold Hemab Therapeutics Holdings shares in Q2 2026, from the holdings they reported to the SEC on Form 13F for March 31, 2026 and June 30, 2026.
Between March 31, 2026 and June 30, 2026, 54 institutions that filed 13F reports for both quarters added to or opened positions in Hemab Therapeutics Holdings, and 0 cut or closed them. Together they added a net 36.2M shares, — on what they held at the start of the quarter. Active managers and hedge funds on our list were net buyers of 24.3M shares; index fund managers were net buyers of 1.5M shares. 54 opened a new position and 0 sold out entirely.
Bought, Q2 2026 54 institutions, 54 of them new holders Sold, Q2 2026 0 institutions, 0 of them sold out
Net change, all compared +36.2M shares (—)
Net change, active managers +24.3M shares (—), 21 bought, 0 sold
Buyers versus sellers
54 bought 0 sold
Active managers and hedge funds 21 bought · 0 sold · +24.3M
Index fund managers 7 bought · 0 sold · +1.5M
Other institutions 26 bought · 0 sold · +10.3M
Biggest buyers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| RA Capital Management, L.P. Hedge fund | +7.8M New position | 7.8M | $287M |
| Novo Holdings A/S | +4.2M New position | 4.2M | $154M |
| FMR LLC Active manager | +3.7M New position | 3.7M | $136M |
| Capital International Investors Active manager | +3.6M New position | 3.6M | $132M |
| Deep Track Capital, LP Hedge fund | +3.6M New position | 3.6M | $132M |
| Siren, L.L.C. | +2.1M New position | 2.1M | $76.6M |
| Avoro Capital Advisors LLC Hedge fund | +1.9M New position | 1.9M | $70.7M |
| Bain Capital Life Sciences Investors, LLC | +1.6M New position | 1.6M | $60.6M |
| Jpmorgan Chase & Co | +1.2M New position | 1.2M | $42.3M |
| Vanguard Capital Management LLC Index funds | +781K New position | 781K | $28.7M |
| Price T Rowe Associates Inc Active manager | +746K New position | 746K | $27.4M |
| Driehaus Capital Management LLC Active manager | +716K New position | 716K | $26.3M |
| Rock Springs Capital Management LP Hedge fund | +575K New position | 575K | $21.1M |
| Bellevue Group AG | +550K New position | 550K | $20.2M |
| Citadel Advisors LLC Hedge fund | +523K New position | 523K | $19.2M |
| Blackrock, Inc. Index funds | +284K New position | 284K | $10.4M |
| Deerfield Management Company, L.P. Hedge fund | +275K New position | 275K | $10.1M |
| Exoduspoint Capital Management, LP Hedge fund | +218K New position | 218K | $8M |
| Geode Capital Management, LLC Index funds | +212K New position | 212K | $7.8M |
| Braidwell LP Hedge fund | +160K New position | 160K | $5.9M |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| RA Capital Management, L.P. Hedge fund | +7.8M New position | 7.8M | $287M |
| FMR LLC Active manager | +3.7M New position | 3.7M | $136M |
| Capital International Investors Active manager | +3.6M New position | 3.6M | $132M |
| Deep Track Capital, LP Hedge fund | +3.6M New position | 3.6M | $132M |
| Avoro Capital Advisors LLC Hedge fund | +1.9M New position | 1.9M | $70.7M |
| Price T Rowe Associates Inc Active manager | +746K New position | 746K | $27.4M |
| Driehaus Capital Management LLC Active manager | +716K New position | 716K | $26.3M |
| Rock Springs Capital Management LP Hedge fund | +575K New position | 575K | $21.1M |
| Citadel Advisors LLC Hedge fund | +523K New position | 523K | $19.2M |
| Deerfield Management Company, L.P. Hedge fund | +275K New position | 275K | $10.1M |
Biggest sellers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| No institution cut its holding. | |||
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| None of the active managers on our list. | |||
New positions
| Institution | Shares | Value June 30, 2026 |
|---|---|---|
| RA Capital Management, L.P.Hedge fund | 7.8M | $287M |
| Novo Holdings A/S | 4.2M | $154M |
| FMR LLCActive manager | 3.7M | $136M |
| Capital International InvestorsActive manager | 3.6M | $132M |
| Deep Track Capital, LPHedge fund | 3.6M | $132M |
| Siren, L.L.C. | 2.1M | $76.6M |
| Avoro Capital Advisors LLCHedge fund | 1.9M | $70.7M |
| Bain Capital Life Sciences Investors, LLC | 1.6M | $60.6M |
| Jpmorgan Chase & Co | 1.2M | $42.3M |
| Vanguard Capital Management LLCIndex funds | 781K | $28.7M |
Sold out
| Institution | Shares | Value March 31, 2026 |
|---|---|---|
| No institution sold its whole holding. | ||
Who holds the shares
- Institutions reporting
- 55
- Ten largest holders
- 84.3% of 13F-reported shares
- Index fund managers
- 4.3% of 13F-reported shares
- Active managers and hedge funds
- 67.2% of 13F-reported shares
| Type | Bought | Sold | New | Sold out | Net change in shares | Net % |
|---|---|---|---|---|---|---|
| Active managers and hedge funds | 21 | 0 | 21 | 0 | +24.3M | — |
| Index fund managers | 7 | 0 | 7 | 0 | +1.5M | — |
| Other institutions | 26 | 0 | 26 | 0 | +10.3M | — |
← Back to Hemab Therapeutics Holdings, Inc. · Insiders · Politicians